首页 | 本学科首页   官方微博 | 高级检索  
     

硫普罗宁治疗抗结核药物性肝损害的临床观察
引用本文:李民,杨静,邱俊林. 硫普罗宁治疗抗结核药物性肝损害的临床观察[J]. 临床医药实践, 2010, 19(1): 21-22
作者姓名:李民  杨静  邱俊林
作者单位:雅安市人民医院,四川雅安,625000
摘    要:
目的:探讨硫普罗宁治疗抗结核药物性肝损害的疗效。方法:121例抗结核药物性肝损害患者,随机分为治疗组61例,对照组60例,治疗组给予硫普罗宁注射液0.2 g加入5%葡萄糖注射液250 mL中静脉滴注,每日1次,对照组给予一般护肝药治疗。结果:两组治疗前比较差异无显著性(P>0.05),治疗组与对照组治疗4周后比较差异有显著性(P<0.05);治疗组治疗7,15,30 d,丙氨酸转移酶(ALT)、总胆红素(TBIL)复常率为78.69%,91.8%和100%,对照组治疗7,15,30 d,ALT、TBIL复常率分别为31.67%,71.67%,90%,治疗组ALT、TBIL复常率优于对照组(P<0.01)。结论:硫普罗宁治疗抗结核药物性肝损害效果明显。

关 键 词:硫普罗宁  药物性肝损害  抗结核药物

Clinical observation of tiopronin on treating liver injury caused by antituberculous drugs
LI Min,YANG Jing,QIU Jun-lin. Clinical observation of tiopronin on treating liver injury caused by antituberculous drugs[J]. Proceeding of Clinical Medicine, 2010, 19(1): 21-22
Authors:LI Min  YANG Jing  QIU Jun-lin
Abstract:
Objective:To investigate the efficacy of tiopronin on treating liver injury caused by antituberculous drugs.Methods:The patients were randomly assigned to two groups,61 cases were in the treatment group treated with tiopronin,60 cases in the control group treated with general liver protectant.Results:There was no statistically difference between the treatment group and the control group before treatment(P>0.05).After 4 weeks of treatment,there were statistically differences between the treatment group and t...
Keywords:tiopronin  medicamentous liver injury  antituberculous drugs  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号